Floatz logo

TESTOSTERONE ENANTATE

Homologous Recombination Deficiency

St Vincent's Hospital, SydneySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Homologous Recombination Deficiency cohort.

Asset / SponsorPhaseRating
Olaparib
Eisbach Bio GmbH
Phase 2BB
Carboplatin
University of Washington
Phase 2B
Niraparib
Latin American Cooperative Oncology Group
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
Fudan University
Phase 2/3B
Pembrolizumab
M.D. Anderson Cancer Center
Phase 2CCC

View all 19 →

Same molecule, other indications

TESTOSTERONE ENANTATE is also rated in:

hypogonadism, maleDormant
BB
Indicative ·
65 / 100
View asset →
erectile dysfunctionDormant
B
Indicative ·
62 / 100
View asset →
castration-resistant prostate carcinomaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →